In this study, we found that there was no significant difference between dexmedetomidine and midazolam in either the proinflammatory pathway, as reflected by CD42a/CD14 + , or the anti-inflammatory pathway, as reflected by HLA-DR + /CD14 + levels, after 24 h of infusion in patients with septic shock. Here, CD14 is linked to septic shock.